Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://chrysbio.com/chrysalis-biotherapeutics-inc-announces-collaboration-with-niaid-to-evaluate-chrysalin-for-the-treatment-of-cutaneous-radiation-injury/
Research Institution
Chrysalis BioTherapeutics, Inc
Short Title
Chrysalis BioTherapeutics, Inc. Announces
Content Coordinator
Claudia Wair
Content Manager
Jennifer Routh